Novo Nordisk A/S (NYSE:NVO)

56.86
Delayed Data
As of Dec 11
 -0.08 / -0.14%
Today’s Change
43.60
Today|||52-Week Range
58.01
+23.42%
Year-to-Date
Is Sanofi's Stock a Buy?
Dec 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close56.94
Today’s open56.61
Day’s range56.58 - 56.92
Volume931,807
Average volume (3 months)1,431,090
Market cap$102.3B
Data as of 6:30pm ET, 12/11/2019

Growth & Valuation

Earnings growth (last year)+8.07%
Earnings growth (this year)-0.03%
Earnings growth (next 5 years)+9.77%
Revenue growth (last year)+4.51%
P/E ratio23.5
Price/Sales6.31
Price/Book17.07

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.14+0.30%
LLYEli Lilly and Co+0.13+0.11%
SNYSanofi+0.92+1.91%
AZNAstraZeneca+0.21+0.44%
Data as of 6:30pm ET, 12/11/2019

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$0.57
Annual revenue (last year)$17.7B
Annual profit (last year)$6.1B
Net profit margin34.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bagsværd, Capital Region

Forecasts